Avalyn Pharma Q2 EPS $(0.65) Misses $(0.53) Estimate
Benzinga Newsdesk 2 months ago
NewsEarningsEarnings Misses
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22.64 percent.
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22.64 percent.